CG Bio Sponsors World UBE Congress in Melbourne

Regenerative medicine company CG Bio sponsored the 2026 World UBE Society Australia Annual Congress held in Melbourne. The event focused on sharing advancements in unilateral biportal endoscopic surgery, also known as UBE. CG Bio showcased a wide range of products, from surgical instruments and imaging equipment to implants and bone regeneration biologics.

During the congress, the company set up an exhibition booth at the RACV City Club and introduced key endoscopic spine surgery equipment. Multifocus, a surgical instrument set developed by CG MedTech, and ELICA 4K, a high-resolution 4K imaging system, were among the main products displayed.

In addition to surgical equipment, CG Bio unveiled several products crucial for spinal fixation and fusion. Notable products included the pedicle screw system Colonnade, the height-expandable spinal cage Xcender, the bone substitute Novosis, and demineralized bone matrix-based bone graft materials Bongener and Allomix. CG Bio currently supplies Novosis to the New Zealand market through Australian distributor LifeHealthcare.

The company aims to expand its biologics and spinal implant product lines in Australia and New Zealand by leveraging its existing distribution network.

CG Bio's CEO, Yu Hyun-seung, emphasized the company's focus on providing comprehensive solutions to medical professionals rather than just individual products. He highlighted that the company would strengthen partnerships in the Australian and New Zealand markets and continue to grow its presence in the global spine surgery market.